EP Patent

EP1764119A1 — Implants with improved osteointegration

Assigned to Nolabs AB · Expires 2007-03-21 · 19y expired

What this patent protects

A coating on an implant, said implant being intended for implantation in/on an implantation area, is provided. The coating comprises nitric oxide (NO) for obtaining an anti-viral, anti-fungal, and anti-bacterial effect, and for promotion of osteo-integration of the implant, bone …

USPTO Abstract

A coating on an implant, said implant being intended for implantation in/on an implantation area, is provided. The coating comprises nitric oxide (NO) for obtaining an anti-viral, anti-fungal, and anti-bacterial effect, and for promotion of osteo-integration of the implant, bone healing, bone growth, and wound healing at said implantation area. An implant and a kit of implants, comprising said coating are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
EP1764119A1
Jurisdiction
EP
Classification
Expires
2007-03-21
Drug substance claim
No
Drug product claim
No
Assignee
Nolabs AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.